International consensus statement on allergy and rhinology: rhinosinusitis 2021

RR Orlandi, TT Kingdom, TL Smith… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …

International consensus statement on allergy and rhinology: rhinosinusitis

RR Orlandi, TT Kingdom, PH Hwang… - International forum of …, 2016 - Wiley Online Library
Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham,
MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav …

[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults

AT Hill, AL Sullivan, JD Chalmers, A De Soyza… - Thorax, 2019 - thorax.bmj.com
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary …

International Consensus Document (ICON): common variable immunodeficiency disorders

FA Bonilla, I Barlan, H Chapel… - The Journal of …, 2016 - jaci-inpractice.org
The International Collaboration in Asthma, Allergy and Immunology initiated an international
coalition among the American Academy of Allergy, Asthma & Immunology; the European …

[HTML][HTML] Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: a large patient cohort study

TI Coulter, A Chandra, CM Bacon, J Babar… - Journal of Allergy and …, 2017 - Elsevier
Background Activated phosphoinositide 3-kinase δ syndrome (APDS) is a recently
described combined immunodeficiency resulting from gain-of-function mutations in PIK3CD …

EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists.

WJ Fokkens, VJ Lund, J Mullol, C Bachert, I Alobid… - Rhinology, 2012 - europepmc.org
The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of
similar evidence based position papers published in 2005 and 2007. The document …

Clinical picture and treatment of 2212 patients with common variable immunodeficiency

B Gathmann, N Mahlaoui, L Gérard… - Journal of Allergy and …, 2014 - Elsevier
Background Common variable immunodeficiency (CVID) is an antibody deficiency with an
equal sex distribution and a high variability in clinical presentation. The main features …

[HTML][HTML] Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis

H Ho, C Cunningham-Rundles - Frontiers in immunology, 2020 - frontiersin.org
Non-infectious complications in common variable immunodeficiency (CVID) have emerged
as a major clinical challenge. Detailed clinical spectrum, organ-specific pathologies and …

[HTML][HTML] COVID-19 outcomes in patients undergoing B cell depletion therapy and those with humoral immunodeficiency states: a scoping review

JM Jones, AJ Faruqi, JK Sullivan… - Pathogens and …, 2021 - ncbi.nlm.nih.gov
Background: The role of humoral immunity has been well established in reducing infection
risk and facilitating viral clearance in patients with COVID-19. However, the relationship …

New concepts in the generation and functions of IgA

O Pabst - Nature Reviews Immunology, 2012 - nature.com
The intestinal mucosa contains the largest population of antibody-secreting plasma cells in
the body, and in humans several grams of secretory immunoglobulin A (SIgA) are released …